Updated findings on dual HER2 inhibition in HER2+ breast cancer
Researchers from the Clínic-IDIBAPS, along with researchers from the Dana Farber Cancer Institute (DFCI) in Boston, have published a review on dual...
News from Institute of Cancer and Blood Diseases
Researchers from the Clínic-IDIBAPS recognized with various grants at the SEOM congress
Five researchers from the Clínic-IDBAPS were recognized with various grants worth a total of €122,000 at the Spanish Society of Medical Oncology (S...
Researchers analyse the efficacy of immunotherapy combined with chemotherapy in the treatment of early breast cancer
Researchers from the Clínic-IDIBAPS have coordinated a study that analyses the efficacy of anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs) comb...
Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet...
Chronic lymphocytic leukaemia: the most common leukaemia in adults that often requires no treatment
September 1st is World Chronic Lymphocytic Leukaemia (CLL) Day, the most common leukaemia in adults. Most patients with CLL respond well to treatme...
Is talcum powder a risk factor for ovarian cancer?
A recent report from an organisation linked to the WHO states that talc is probably carcinogenic to humans. The use of talc is considered to increa...
Green light for ARI0002h CAR-T developed by Clínic-IDIBAPS for patients with multiple myeloma
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved AR...
The FERO Foundation and the Clínic-IDIBAPS join Forces for Cancer Research
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Program...
A new 3D model is developed to simulate the tumour microenvironment of a type of lymphoma
Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples...
Biomarkers of response to CAR T-cell therapy with ARI-0002h in refractory multiple myeloma are described
A study published recently in the journal Clinical Cancer Research identified biomarkers that can predict the response to CAR T-cell therapy target...